Literature DB >> 11238029

Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis.

S Ross1, S D Spencer, L A Lasky, H Koeppen.   

Abstract

Prostate stem cell antigen (PSCA) is a GPI-anchored membrane protein whose expression is reportedly up-regulated in a majority of human prostate cancers, including advanced stages and metastases. In this study, we investigate the expression pattern of the murine orthologue of PSCA by in situ hybridization in fetal and adult mouse tissues. Murine PSCA is expressed during fetal development in the urogenital sinus, skin, and gastrointestinal tract. The expression in these tissues is restricted to the most superficial cell layer. In the adult mouse, expression is highest in the mucosal lining of the urinary tract. In the normal adult prostate, expression of PSCA is detected exclusively in the secretory epithelium. Examination of PSCA during carcinogenesis of the murine prostate in the transgenic adenocarcinoma of the mouse prostate model showed a markedly increased expression in areas of neoplasia. The transgenic adenocarcinoma of the mouse prostate model may represent a valuable model for the study of PSCA as a potential target for immunotherapy of prostate cancer, despite potential differences in the pattern of expression between mice and humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238029      PMCID: PMC1850373          DOI: 10.1016/S0002-9440(10)64028-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

Review 1.  Immunological approaches for the treatment of prostate cancer.

Authors:  S F Slovin; W K Kelly; H I Scher
Journal:  Semin Urol Oncol       Date:  1998-02

2.  Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.

Authors:  R E Reiter; Z Gu; T Watabe; G Thomas; K Szigeti; E Davis; M Wahl; S Nisitani; J Yamashiro; M M Le Beau; M Loda; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 3.  Basic science aspects of prostate cancer.

Authors:  T J Dorkin; D E Neal
Journal:  Semin Cancer Biol       Date:  1997-02       Impact factor: 15.707

4.  Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors.

Authors:  G Bahrenberg; A Brauers; H G Joost; G Jakse
Journal:  Biochem Biophys Res Commun       Date:  2000-09-07       Impact factor: 3.575

5.  Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer.

Authors:  R E Reiter; I Sato; G Thomas; J Qian; Z Gu; T Watabe; M Loda; R B Jenkins
Journal:  Genes Chromosomes Cancer       Date:  2000-01       Impact factor: 5.006

6.  Prostate cancer in a transgenic mouse.

Authors:  N M Greenberg; F DeMayo; M J Finegold; D Medina; W D Tilley; J O Aspinall; G R Cunha; A A Donjacour; R J Matusik; J M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

7.  Expression of Ly-6, a marker for highly malignant murine tumor cells, is regulated by growth conditions and stress.

Authors:  A Treister; O Sagi-Assif; M Meer; N I Smorodinsky; R Anavi; I Golan; T Meshel; O Kahana; R Eshel; B Z Katz; E Shevach; I P Witz
Journal:  Int J Cancer       Date:  1998-07-17       Impact factor: 7.396

8.  Metastatic prostate cancer in a transgenic mouse.

Authors:  J R Gingrich; R J Barrios; R A Morton; B F Boyce; F J DeMayo; M J Finegold; R Angelopoulou; J M Rosen; N M Greenberg
Journal:  Cancer Res       Date:  1996-09-15       Impact factor: 12.701

9.  DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications.

Authors:  C Van Den Berg; X Y Guan; D Von Hoff; R Jenkins; C Griffin; O Kallioniemi; J Herath
Journal:  Clin Cancer Res       Date:  1995-01       Impact factor: 12.531

10.  Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.

Authors:  T Visakorpi; A H Kallioniemi; A C Syvänen; E R Hyytinen; R Karhu; T Tammela; J J Isola; O P Kallioniemi
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

View more
  6 in total

1.  Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter.

Authors:  Tetsuro Watabe; Mark Lin; Hisamitsu Ide; Annemarie A Donjacour; Gerald R Cunha; Owen N Witte; Robert E Reiter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Urine cytology and adjunct markers for detection and surveillance of bladder cancer.

Authors:  Peggy S Sullivan; Jessica B Chan; Mary R Levin; Jianyu Rao
Journal:  Am J Transl Res       Date:  2010-07-25       Impact factor: 4.060

Review 3.  Prostate stem cell antigen: a prospective therapeutic and diagnostic target.

Authors:  Adam B Raff; Andrew Gray; W Martin Kast
Journal:  Cancer Lett       Date:  2008-10-05       Impact factor: 8.679

4.  Positive and negative regulation of prostate stem cell antigen expression by Yin Yang 1 in prostate epithelial cell lines.

Authors:  Shuai Tang; Meenu Mishra; Donna P Frazier; Miranda L Moore; Kazushi Inoue; Rajendar Deora; Guangchao Sui; Purnima Dubey
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

5.  Regenerative potential of prostate luminal cells revealed by single-cell analysis.

Authors:  Wouter R Karthaus; Matan Hofree; Danielle Choi; Eliot L Linton; Mesruh Turkekul; Alborz Bejnood; Brett Carver; Anuradha Gopalan; Wassim Abida; Vincent Laudone; Moshe Biton; Ojasvi Chaudhary; Tianhao Xu; Ignas Masilionis; Katia Manova; Linas Mazutis; Dana Pe'er; Aviv Regev; Charles L Sawyers
Journal:  Science       Date:  2020-05-01       Impact factor: 47.728

Review 6.  Cancer therapy using tumor-associated antigens to reduce side effects.

Authors:  David Siu
Journal:  Clin Exp Med       Date:  2009-05-01       Impact factor: 5.057

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.